The Ultra-Potent and Selective TLR8 Agonist VTX-294 Activates Human Newborn and Adult Leukocytes

BACKGROUND: Newborns display distinct immune responses that contribute to susceptibility to infection and reduced vaccine responses. Toll-like receptor (TLR) agonists may serve as vaccine adjuvants, when given individually or in combination, but responses of neonatal leukocytes to many TLR agonists...

Descripción completa

Detalles Bibliográficos
Autores principales: Dowling, David J., Tan, Zhen, Prokopowicz, Zofia M., Palmer, Christine D., Matthews, Maura-Ann H., Dietsch, Gregory N., Hershberg, Robert M., Levy, Ofer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3587566/
https://www.ncbi.nlm.nih.gov/pubmed/23483986
http://dx.doi.org/10.1371/journal.pone.0058164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3587566/
https://www.ncbi.nlm.nih.gov/pubmed/23483986
http://dx.doi.org/10.1371/journal.pone.0058164

Ejemplares similares